Literature DB >> 26323874

Review of New Statistical Techniques for Analysis of Cardiovascular Trial and Registry Data.

Dhammika Amaratunga1, Javier Cabrera.   

Abstract

Cardiovascular research generates a large variety of data including big and small datasets that pose interesting challenges to researchers in biomedical statistics. This paper covers a number of important methodology issues and the solutions that have been applied so far to try to solve them. The first issue is multiple testing and the use of false discovery rates to correct for multiplicity. This is illustrated with an application related to genotyping heart diseases. The second is measuring life extension at present and in the future. The third one is the issue of U and J curves and the questions they present. Finally, this paper studies visit-to-visit blood pressure variability as a predictor of cardiovascular events.

Entities:  

Mesh:

Year:  2015        PMID: 26323874     DOI: 10.1007/s11906-015-0591-8

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   5.369


  7 in total

1.  Identifying common genetic variants in blood pressure due to polygenic pleiotropy with associated phenotypes.

Authors:  Ole A Andreassen; Linda K McEvoy; Wesley K Thompson; Yunpeng Wang; Sjur Reppe; Andrew J Schork; Verena Zuber; Elizabeth Barrett-Connor; Kaare Gautvik; Pål Aukrust; Tom H Karlsen; Srdjan Djurovic; Rahul S Desikan; Anders M Dale
Journal:  Hypertension       Date:  2014-01-06       Impact factor: 10.190

2.  Blood pressure and outcomes in very old hypertensive coronary artery disease patients: an INVEST substudy.

Authors:  Scott J Denardo; Yan Gong; Wilmer W Nichols; Franz H Messerli; Anthony A Bavry; Rhonda M Cooper-Dehoff; Eileen M Handberg; Annette Champion; Carl J Pepine
Journal:  Am J Med       Date:  2010-08       Impact factor: 4.965

3.  Association between chlorthalidone treatment of systolic hypertension and long-term survival.

Authors:  John B Kostis; Javier Cabrera; Jerry Q Cheng; Nora M Cosgrove; Yingzi Deng; Sara L Pressel; Barry R Davis
Journal:  JAMA       Date:  2011-12-21       Impact factor: 56.272

4.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

5.  Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). TONE Collaborative Research Group.

Authors:  P K Whelton; L J Appel; M A Espeland; W B Applegate; W H Ettinger; J B Kostis; S Kumanyika; C R Lacy; K C Johnson; S Folmar; J A Cutler
Journal:  JAMA       Date:  1998-03-18       Impact factor: 56.272

6.  Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension.

Authors:  Peter M Rothwell; Sally C Howard; Eamon Dolan; Eoin O'Brien; Joanna E Dobson; Bjorn Dahlöf; Peter S Sever; Neil R Poulter
Journal:  Lancet       Date:  2010-03-13       Impact factor: 79.321

7.  Visit-to-visit blood pressure variability and cardiovascular death in the Systolic Hypertension in the Elderly Program.

Authors:  John B Kostis; Jeanine E Sedjro; Javier Cabrera; Nora M Cosgrove; John S Pantazopoulos; William J Kostis; Sara L Pressel; Barry R Davis
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-12-11       Impact factor: 3.738

  7 in total
  1 in total

1.  Use of advanced statistical techniques to predict all-cause mortality in the Systolic Blood Pressure Intervention Trial.

Authors:  William J Kostis; Javier Cabrera; Chun Pang Lin; John B Kostis; Jennifer Wellings; Stavros Zinonos; Jeanne M Dobrzynski; Daniel Blickstein
Journal:  Int J Cardiol Hypertens       Date:  2020-09-19
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.